Bousmah Marwân-Al-Qays, Nishimwe Marie Libérée, Tovar-Sanchez Tamara, Lantche Wandji Martial, Mpoudi-Etame Mireille, Maradan Gwenaëlle, Omgba Bassega Pierrette, Varloteaux Marie, Montoyo Alice, Kouanfack Charles, Delaporte Eric, Boyer Sylvie. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). PharmacoEconomics. 2021;39(3):331-343.